A guide to care visits
A clear offer leaves room for checking
Look past approval language, research labels and badges to the records and explanations behind the offer.
Pause when an offer avoids the basic questions
If the explanation feels rushed, ask for it in writing. Take time to discuss the offer before agreeing to treatment or payment.
Under the US rule recorded as of September 26, 2026, a pharmacy needs a valid prescription from someone licensed to prescribe before it supplies a prescription medicine.
Compare checkable answers with reassurance
“The compound is approved”
A compounded medicine is made to order. Medicine approvals in the US come from the Food and Drug Administration, or FDA.
A pharmacy licence does not give its made-to-order medicines FDA approval; these medicines remain unapproved, as checked on September 26, 2026.
“The research label makes it fine”
In the September 26, 2026 record, FDA cautions that research-labelled products offered as treatment have unknown quality and could harm people.
“The badge proves the service”
Seals and logos can be forged to make a health website seem legitimate, cautions the Federal Trade Commission.
Use the names behind the offer to check state licence records. Ask separately why this medicine is being suggested for your concern.
Bring the unanswered question back to the service
- No named person treating you
- Ask who makes the decision, what their qualification is and how you can speak with them.
- No named pharmacy
- Ask which pharmacy supplies the medicine and which pharmacy or business makes it to order, if needed.
- No clear follow-up
- Ask who responds when a question arises after the visit.
If those answers remain unclear, leave the offer open while you seek another assessment.